PHARMACOLOGICAL PROFILE AND INSULIN SECRETAGOGUE EFFECT OF LINOGLIRIDE (MCN-3935), A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT

被引：11

作者：

TUTWILER, GF ^{[1
]}

TUMAN, RW ^{[1
]}

JOSEPH, JM ^{[1
]}

MIHAN, BB ^{[1
]}

FAWTHROP, H ^{[1
]}

BRENTZEL, HJ ^{[1
]}

机构：

[1] MCNEIL PHARMACEUT,DEPT BIOL RES,ENDOCRINOL & METAB SECT,WELSH & MCKEAN RD,SPRING HOUSE,PA 19477

来源：

DRUG DEVELOPMENT RESEARCH | 1986年 / 9卷 / 04期

关键词：

D O I：

10.1002/ddr.430090405

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：273 / 292

页数：20

共 26 条

[1]

BANERJI M, 1985, DIABETES S1, V34, pA61

[2] INSULIN CONCENTRATIONS IN PORTAL VENOUS AND PERIPHERAL VENOUS-BLOOD IN MAN FOLLOWING ADMINISTRATION OF GLUCOSE, GALACTOSE, XYLITOL AND TOLBUTAMIDE [J].

BERGER, W ;

GOSCHKE, H ;

MOPPERT, J ;

KUNZLI, H .

HORMONE AND METABOLIC RESEARCH, 1973, 5 (01) :4-8

[3] PORTAL AND PERIPHERAL VEIN IMMUNOREACTIVE INSULIN CONCENTRATIONS BEFORE AND AFTER GLUCOSE INFUSION [J].

BLACKARD, WG ;

NELSON, NC .

DIABETES, 1970, 19 (05) :302-&

[4] RELATIONSHIPS BETWEEN FASTING PLASMA GLUCOSE LEVELS AND INSULIN-SECRETION DURING INTRAVENOUS GLUCOSE-TOLERANCE TESTS [J].

BRUNZELL, JD ;

ROBERTSON, RP ;

LERNER, RL ;

HAZZARD, WR ;

ENSINCK, JW ;

BIERMAN, EL ;

PORTE, D .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (02) :222-229

[5] DECREASED SENSITIVITY OF PANCREATIC BETA CELLS TO GLUCOSE IN PREDIABETIC AND DIABETIC SUBJECTS - GLUCOSE DOSE-RESPONSE STUDY [J].

CERASI, E ;

EFENDIC, S ;

LUFT, R .

DIABETES, 1972, 21 (04) :224-&

[6]

FINNEY DJ, 1964, STATISTICAL METHOD B

[7]

GERRITSEN GC, 1967, P SOC EXP BIOL MED, V126, P524

[8] EFFECTS OF HYPOGLYCEMIC AGENTS ON VASCULAR COMPLICATIONS IN PATIENTS WITH ADULT-ONSET DIABETES .3. CLINICAL IMPLICATIONS OF UGDP RESULTS [J].

GOLDNER, MG ;

KNATTERUD, GL ;

PROUT, TE .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 218 (09) :1400-+

[9] PHENFORMIN INDUCED LACTIC ACIDOSIS - CASE REPORT AND REVIEW OF LITERATURE [J].

GONG, WC ;

KATO, DB .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1975, 9 (05) :236-240

[10] A NOVEL, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT, SARI-59-801, IN LABORATORY-ANIMALS [J].

HO, RS ;

WISEBERG, JJ ;

BRAND, LJ ;

NADELSON, J ;

BOYAJY, LD .

DRUG DEVELOPMENT RESEARCH, 1985, 6 (01) :67-77

← 1 2 3 →